Skip to main content

Client News

Bayer and Aignostics to collaborate on next generation precision oncology

14th March 2024

Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence

12th March 2024

FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region

11th March 2024

MIG Capital: MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging

11th March 2024

Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024isease transgenic model to be presented at AD/PD™ 2024 Conference

8th March 2024

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023

6th March 2024

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic

5th March 2024

CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances

5th March 2024

Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve

29th February 2024

AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board

29th February 2024